Alnylam Pharmaceuticals ALNY
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 270.02 | -612.78 | -0.44 | 18,077 | -57 | |
| 2024Q4 | 235.31 | 67.85 | -0.65 | -105,159 | -84 | |
| 2024Q3 | 275.03 | 103.52 | -0.87 | -76,905 | -112 | |
| 2024Q2 | 243.00 | 220.06 | -0.14 | 48,614 | -17 | |
| 2024Q1 | 149.45 | 153.30 | -0.52 | -43,435 | -66 | |
| 2023Q4 | 191.41 | 109.45 | -1.09 | -116,404 | -138 | |
| 2023Q3 | 177.10 | 117.75 | 1.19 | 213,867 | 148 | |
| 2023Q2 | 189.94 | 94.13 | -2.22 | -229,831 | -276 | |
| 2023Q1 | 200.32 | 104.46 | -1.40 | -149,807 | -174 | |
| 2022Q4 | 237.65 | 106.50 | -1.68 | -188,614 | -207 | |
| 2022Q3 | 200.16 | 70.72 | -3.33 | -258,040 | -406 | |
| 2022Q2 | 145.85 | 82.60 | -2.29 | -191,686 | -277 | |
| 2022Q1 | 163.29 | 74.49 | -2.00 | -146,732 | -240 | |
| 2021Q4 | 169.58 | 87.06 | -2.16 | -194,561 | -258 | |
| 2021Q3 | 188.81 | 110.80 | -1.72 | -181,677 | -205 | |
| 2021Q2 | 169.52 | 94.35 | -1.61 | -146,160 | -190 | |
| 2021Q1 | 141.19 | 111.69 | -1.71 | -186,254 | -200 | |
| 2020Q4 | 129.97 | 90.30 | -2.09 | -194,222 | -244 | |
| 2020Q3 | 145.60 | 100.66 | -2.19 | -225,199 | -253 | |
| 2020Q2 | 148.11 | 132.00 | -1.56 | -198,859 | -179 |